Given the clinical characteristics of high-grade breast cancers, we hypothesized that WAVE3 might be expressed at higher levels compared to low grade tumors and this elevated expression might contribute to the increased metastatic potential seen in the high-grade tumors compared to low-grade tumors. The gene discussed is WASF3; the disease is breast cancer.